Novo CEO pressed by Senate to cut price ranges of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the company would think about new talks with insurers regarding the listing rates of Wegovy and copyright if they pledge to keep the medicines on their own formularies. https://kethek.com/